[Translation] An open-label Phase I/II study evaluating the safety, tolerability, pharmacokinetics, immunogenicity and preliminary anti-tumor activity of BT02 in patients with advanced solid tumors
评估BT02在晚期实体瘤患者中的安全性、耐受性、药代动力学、免疫原性和初步抗肿瘤活性的开放标签I/II期研究。
[Translation] An open-label Phase I/II study evaluating the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary anti-tumor activity of BT02 in patients with advanced solid tumors.